Dashboard
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Net Sales has grown by an annual rate of -43.74% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
Negative results in Jan 70
Risky - No result in last 6 months
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 13 Cr (Micro Cap)
NA (Loss Making)
40
0.00%
-1.32
7.73%
-0.07
Total Returns (Price + Dividend) 
Latest dividend: 1.5 per share ex-dividend date: Sep-15-2016
Risk Adjusted Returns v/s 
Returns Beta
News

Omkar Speciality Chemicals Ltd is Rated Strong Sell
Omkar Speciality Chemicals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 25 Nov 2024, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 26 December 2025, providing investors with the latest data to inform their decisions.
Read More
Omkar Speciality Chemicals Hits Upper Circuit Amid Strong Buying Pressure
Omkar Speciality Chemicals Ltd witnessed robust buying interest on 26 Dec 2025, hitting its upper circuit limit and registering a maximum daily gain of 4.41%. The stock outperformed its sector and broader market indices, reflecting heightened investor enthusiasm despite its micro-cap status.
Read More
Omkar Speciality Chemicals Hits Upper Circuit Amid Strong Buying Pressure
Omkar Speciality Chemicals Ltd witnessed a robust trading session on 15 Dec 2025, hitting its upper circuit limit with a maximum daily gain of 4.99%, reflecting intense buying interest and a surge in demand that led to a regulatory trading freeze for the day.
Read More Announcements 
Outcome Of The 1St Meeting Of The Monitoring Committee Of The Company In Terms Of The Provisions Of Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosures Requirements) Regulations 2015 As Amended
13-Aug-2025 | Source : BSEOutcome of the 1st Meeting of the Monitoring Committee of the Company in terms of the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended
Intimation Of Meeting Of 1St (First) Monitoring Committee Of Omkar Speciality Chemicals Limited (The Company) Scheduled To Be Held On Wednesday August 13 2025
12-Aug-2025 | Source : BSEIntimation of meeting of 1st (First) Monitoring Committee of the Company scheduled to be held on Wednesday August 13 2025
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
20-Aug-2023 | Source : BSENotice of 6th COC meeting of the Company
Corporate Actions 
No Upcoming Board Meetings
Omkar Speciality Chemicals Ltd has declared 15% dividend, ex-date: 15 Sep 16
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2022
Shareholding Compare (%holding) 
Non Institution
56.729
Held by 0 Schemes
Held by 1 FIIs (0.06%)
Pravin Shivdas Herlekar (10.35%)
None
72.8%
Quarterly Results Snapshot (Standalone) - Jun'22 - YoY
YoY Growth in quarter ended Jun 2022 is -49.18% vs 43.19% in Jun 2021
YoY Growth in quarter ended Jun 2022 is -27.19% vs -70.15% in Jun 2021
Half Yearly Results Snapshot (Standalone) - Sep'21
Growth in half year ended Sep 2021 is -47.32% vs -25.83% in Sep 2020
Growth in half year ended Sep 2021 is -394.92% vs 77.00% in Sep 2020
Nine Monthly Results Snapshot (Standalone) - Dec'21
YoY Growth in nine months ended Dec 2021 is -47.51% vs -22.52% in Dec 2020
YoY Growth in nine months ended Dec 2021 is -1,247.37% vs 93.82% in Dec 2020
Annual Results Snapshot (Standalone) - Mar'22
YoY Growth in year ended Mar 2022 is -49.07% vs -20.68% in Mar 2021
YoY Growth in year ended Mar 2022 is -727.36% vs 113.73% in Mar 2021






